Review Article
Niosomes as Nanoparticular Drug Carriers: Fundamentals and Recent Applications
Table 2
Niosomes in targeted drug delivery.
| Targeted tissue | Loaded therapeutic agent | Composition | Preparation method | Surface modification | Targeting molecule | References |
| Brain | Doxorubicin | Span 60, cholesterol, solulan C24, N-palmitoyl glucosamine | TLE-paddle method | — | N-Palmitoyl glucosamine | [30] | Dynorphin-B | Span 60, cholesterol, solulan C24, N-palmitoyl glucosamine | Sonication | — | N-Palmitoyl glucosamine | [26] | Vasoactive intestinal peptide | Span 60, cholesterol, solulan C24, N-palmitoyl glucosamine | Sonication | — | N-Palmitoyl glucosamine | [31] |
| Breast cancer | Doxorubicin | Oxidate pluronic L64, cholesterol | Thin-film hydration | EDC Chemistry | Transferrin | [24] |
| Chronic myelogenous leukemia | Doxorubicin | Tween 60, pluronic L64 | Thin-film hydration | — | Magnetite | [32] |
| Epidermoid carcinoma | Hydroxycamptothecin | Span 60, cholesterol | Thin-film hydration | Periodate oxidation | Transferrin | [33] | Doxorubicin | Span 60, cholesterol, solulan C24, N-palmitoyl glucosamine | Sonication | — | N-Palmitoyl glucosamine | [34] |
| Melanoma | Doxorubicin | Span 60, cholesterol, dicetyl phosphate, N-lauryl glucosamine | Ethanol injection method | — | N-Lauryl glucosamine | [35] |
|
|